Overview / Abstract: |
The immune checkpoint inhibitors (ICIs) continue to break ground in a multitude of cancer types. With ever-evolving data and recommendations, oncology clinicians must keep pace with the latest ICI updates. This recorded CME-certified session tackles questions surrounding topics related to immune checkpoint inhibitors with discussion on: This session also features Q&A from the meeting highlighting common questions related to immunooncology IO treatments. |
Expiration |
Jun 03, 2022 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Radiology / RAD Tech CE |
Format |
Webinar / Webcast / Video |
Credits / Hours |
1.0 |
Accreditation |
ACCME and ACPE |
Presenters / Authors / Faculty |
Douglas Johnson, MD, MSCI Brian Rini, MD, FASCO |
Activity Specialities / Related Topics |
Oncology / Cancer / Radiation Therapy, Pharmacology |
Sponsors / Supporters / Grant Providers |
Sponsored by the Academy for Continued Healthcare Learning (ACHL). |
Keywords / Search Terms |
ACHL CME, Continuing Medical Education, CME/CE, ACPE, pharmacy, pharmacy credit, Cardinal Health, Streaming CME, Webinar, Webcast, biomarkers, ICI, lung cancer, kidney cancer, bladder cancer, Immune-related adverse events (irAEs), NCCN recommendations, immunooncology strategies, ovel immune checkpoints, Oncolytic viruses, CAR-T cell therapies, Douglas Johnson, MD, MSCI, Brian Rini, MD, FASCO Free CE CME |